Carregant...
Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy
Approximately half of all HER2/neu-overexpressing breast cancer patients do not respond to trastuzumab-containing therapy. Therefore, there remains an urgent and unmet clinical need for the development of predictive biomarkers for trastuzumab response. Recently, several lines of evidence have demons...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3530544/ https://ncbi.nlm.nih.gov/pubmed/23300545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0051379 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|